November 25, 2022
Chugai Pharmaceutical will transfer the business of its osteoporosis treatment Bonviva (ibandronate) to Taisho Pharmaceutical in Japan as it braces for generic entries for the drug’s IV injection version later this year. The two companies said on November 24 that...read more